Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Drug major Cipla is betting big on digitisation and emerging segments like biosimilars and mRNA aided medications to drive its next phase of growth

Cipla betting big on digitisation and emerging segments like mRNA

Cipla is betting big on digitisation and segments like biosimilars and mRNA-aided medications to drive its next phase of growth.

Cipla Betting Big On Digitisation And Emerging Segments

The drug firm has embarked on the digital transformation of the value chain across functions, including finance, R&D, manufacturing, supply chain, HR, customer outreach and stakeholder engagement, she added.

Cipla betting big on digitisation and emerging segments

On Monday of next week, the following stocks will begin trading ex-dividend: D. B. Corp Limited, ICICI Bank, Castrol India Limited, Honeywell Automation India Limited, Alkem Laboratories Limited, Cipla Ltd, and Chennai Petroleum Corporation Limited.

7 stocks to turn ex-dividend next week on Monday: Check if you own any

“There is a move towards more complex generics which are higher margin and are subject to less price erosion in the US and also in the advanced markets. The US has traditionally been stronger pricing wise versus Europe. Against this whole backdrop, Lupin and Cipla because of the move towards comple…

Can pharma sustain the rally? Chakri Lokapriya answers

Pricing pressure continues to remain a key headwind for the growth of pharma companies in the US market

Sun, Cipla’s US show tops Dr Reddy’s, Lupin in Q1

फार्मा कंपनी Cipla के जून तिमाही के नतीजे अनुमान से बेहतर रहे हैं.शेयर पर ब्रोकरेज हाउस काफी पॉजिटिव है.सभी ब्रोकरेज हाउस ने Buy और ओवरवेट की रेटिंग बरकरार रखी है. शेयर निवेशकों को अच्छा रिटर्न दे सकता है.

#Cipla #BrokerageHouse #ZeeBusiness


About Zee Business
--------------------------
 
Zee Business is India's Number 1 Hindi business news channel. It's your channel for profit and wealth. Watch Live coverage of Indian markets - Sensex & Nifty, also for expert insights and advise from our team of experts.
 
--------------------------------------------------------------
 
You can also visit us at:
https://goo.gl/sXWpTF
 
Like us on Facebook:
https://goo.gl/OMJgrn
 
Follow us on Twitter:
https://goo.gl/OjOzpB
 
Subscribe to our other network channels:
Zee News: https://goo.gl/XBvkjZ

Follow us on Google News for latest updates

Zee News:- https://bit.ly/2Ac5G60
Zee Business:- https://bit.ly/36vI2xa
DNA India:- https://bit.ly/2ZDuLRY
WION: https://bit.ly/3gnDb5J
Zee News Apps : https://bit.ly/ZeeNewsApps

Cipla के  Q1 नतीजों के बाद ब्रोकरेज ने दी खरीदारी की सलाह, जानिए क्या है नए टारगेट

Stocks to Watch today: ITC, UPL, Zomato, Arvind, Bajaj Consumer Care, among others will release their Q1 earnings today.

Stocks to Watch: YES Bank, Cipla, Bank of Baroda, Zomato, HDFC, ITC, NTPC

Cipla Q1 Review - Pipeline Build-Up On Track In The Respiratory, Peptide Space: Motilal Oswal

Cipla reported net profit of ₹686 crore during for the quarter ended June, down 4% from ₹715 crore for the first quarter of FY22, mainly due to sharp normalisation in Covid portfolio contribution. Its first quarter revenue dropped 2% year on year to ₹5,375 crore from ₹5,504 crore.

Cipla in talks to repurpose drugs for Monkeypox, Q1 profit falls 4% to ₹686 cr

Domestic revenue dips 8.4% as Covid-19 share of branded prescription business normalises; North American business up 10% to $155 million

Cipla Q1 net dips 4% to Rs 686 cr, revenue down 2% on tapering Covid sales

Cipla Limited is a pharmaceutical company. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology & cosmetology, diabetes, HIV/AIDS, infectious diseases & critical care, malaria etc.

Cipla Ltd

Cipla Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Cipla betting big on digitisation and emerging segments like mRNA

Cipla Betting Big On Digitisation And Emerging Segments

Cipla betting big on digitisation and emerging segments

7 stocks to turn ex-dividend next week on Monday: Check if you own any

Can pharma sustain the rally? Chakri Lokapriya answers

Sun, Cipla’s US show tops Dr Reddy’s, Lupin in Q1

News Video

Cipla के Q1 नतीजों के बाद ब्रोकरेज ने दी खरीदारी की सलाह, जानिए क्या है नए टारगेट

Cipla Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Cipla betting big on digitisation and emerging segments like mRNA

Cipla Betting Big On Digitisation And Emerging Segments

Cipla betting big on digitisation and emerging segments

7 stocks to turn ex-dividend next week on Monday: Check if you own any

Can pharma sustain the rally? Chakri Lokapriya answers

Sun, Cipla’s US show tops Dr Reddy’s, Lupin in Q1

News Video

Cipla के Q1 नतीजों के बाद ब्रोकरेज ने दी खरीदारी की सलाह, जानिए क्या है नए टारगेट

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock